Podrobno

Development and validation of an LC-MS/MS bioanalytical method for simultaneous determination of five main metabolites from the folate-methionine cycle in biological samples : implications for anti-folate treatment
ID Rotman Primec, Jaka (Avtor), ID Geršak, Ksenija (Avtor), ID Mlinarič-Raščan, Irena (Avtor), ID Urbančič, Dunja (Avtor), ID Roškar, Robert (Avtor)

.pdfPDF - Predstavitvena datoteka, prenos (1,61 MB)
MD5: 2BEA90E3C01383D21645F0D897940300
URLURL - Izvorni URL, za dostop obiščite https://www.sciencedirect.com/science/article/pii/S0026265X2503749X Povezava se odpre v novem oknu

Izvleček
The folate-methionine cycle metabolites are essential for methylation reactions and cell growth, with their imbalances implicated in cardiovascular disease, neural tube defects, cancer, and psychiatric disorders. Reliable quantification of these metabolites is important for disease prevention and monitoring of antifolate therapies. However, existing analytical methods are often limited by a low number of analytes, lengthy sample preparation, high reagent consumption, derivatisation requirements or lack of efficiency for simultaneous analysis. In this study, we report the development and validation of a liquid chromatography-tandem mass spectrometry method for the simultaneous quantification of five key metabolites: 5-methyltetrahydrofolate, S-adenosylmethionine, S-adenosylhomocysteine, folic acid, and homocysteine in biological samples utilising simple and fast sample preparation by protein precipitation. Method validation followed the guideline M10 on bioanalytical method validation, demonstrating selectivity, concentration-response relationship, precision, accuracy and stability across short- and long-term storage. The method covered wide dynamic ranges between the lower and upper limits of quantification, namely 50–4000 μg/L for homocysteine, 500–10,000 μg/L for S-adenosylmethionine, 2.5–50 μg/L for S-adenosylhomocysteine, 2.5–100 μg/L for folic acid and 2.5–50 μg/L for 5-methyltetrahydrofolate. In addition, the method's robustness was shown in endogenous matrices of six different cell lines. Applicability was demonstrated on human lymphoblastoid cells treated with methotrexate, a known antifolate, revealing expected metabolic changes; increase in intracellular levels of folic acid and homocysteine, and decreased levels of 5-methyltetrahydrofolate and S-adenosylmethionine. These results highlight the ability of the method to detect metabolic changes and its potential as a robust tool for assessing methylation and folate status in biomedical research.

Jezik:Angleški jezik
Ključne besede:LC-MS/MS, folic acid, 5-methyltetrahydrofolate, S-adenosylmethionine, S-adenosylhomocysteine, homocysteine, cell lysates
Vrsta gradiva:Članek v reviji
Tipologija:1.01 - Izvirni znanstveni članek
Organizacija:FFA - Fakulteta za farmacijo
MF - Medicinska fakulteta
Status publikacije:Objavljeno
Različica publikacije:Objavljena publikacija
Leto izida:2026
Št. strani:10 str.
Številčenje:Vol. 220, art. 116399
PID:20.500.12556/RUL-182833 Povezava se odpre v novem oknu
UDK:543.2/.9
ISSN pri članku:1095-9149
DOI:10.1016/j.microc.2025.116399 Povezava se odpre v novem oknu
COBISS.SI-ID:260447235 Povezava se odpre v novem oknu
Datum objave v RUL:25.05.2026
Število ogledov:121
Število prenosov:130
Metapodatki:XML DC-XML DC-RDF
:
Kopiraj citat
Objavi na:Bookmark and Share

Gradivo je del revije

Naslov:Microchemical journal
Založnik:Elsevier
ISSN:1095-9149
COBISS.SI-ID:23088645 Povezava se odpre v novem oknu

Licence

Licenca:CC BY 4.0, Creative Commons Priznanje avtorstva 4.0 Mednarodna
Povezava:http://creativecommons.org/licenses/by/4.0/deed.sl
Opis:To je standardna licenca Creative Commons, ki daje uporabnikom največ možnosti za nadaljnjo uporabo dela, pri čemer morajo navesti avtorja.

Sekundarni jezik

Jezik:Slovenski jezik
Ključne besede:LC-MS/MS, folna kislina, 5-metiltetrahidrofolat, S-adenozilmetionin, S-adenozilhomocistein, homocistein, celični lizati, tekočinska kromatografija, masna spektrometrija

Projekti

Financer:ARRS - Agencija za raziskovalno dejavnost Republike Slovenije
Številka projekta:P1-0208
Naslov:Farmacevtska kemija: načrtovanje, sinteza in vrednotenje učinkovin

Financer:ARRS - Agencija za raziskovalno dejavnost Republike Slovenije
Številka projekta:P1-0189
Naslov:Farmacevtska tehnologija: od dostavnih sistemov učinkovin do terapijskih izidov zdravil pri otrocih in starostnikih

Financer:ARRS - Agencija za raziskovalno dejavnost Republike Slovenije
Številka projekta:P3-0124
Naslov:Metabolni in prirojeni dejavniki reproduktivnega zdravja, porod III

Financer:ARRS - Agencija za raziskovalno dejavnost Republike Slovenije
Program financ.:Young researchers

Financer:Ministry of Higher Education, Science and Innovation
Številka projekta:OP20.05187
Akronim:RI-SI-EATRIS

Financer:EC - European Commission
Program financ.:European Regional Development Fund
Akronim:RI-SI-EATRIS

Financer:EC - European Commission
Program financ.:HE
Številka projekta:101057442
Naslov:Building a sustainable European innovation platform to enhance the repurposing of medicines for all
Akronim:REMEDi4ALL

Podobna dela

Podobna dela v RUL:
Podobna dela v drugih slovenskih zbirkah:

Nazaj